Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1998
12/30/1998EP0801570A4 Formulations and methods for reducing skin irritation
12/30/1998EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
12/30/1998EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate
12/30/1998CN1041383C Method of preparing composition for effective depressing of woman ovulation
12/30/1998CA2295094A1 Method of treating heart failure
12/30/1998CA2294283A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent
12/30/1998CA2294169A1 Therapeutic method for management of diabetes mellitus
12/30/1998CA2294155A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/30/1998CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
12/29/1998US5854411 Human chloride channel
12/29/1998US5854382 Bioresorbable compositions for implantable prostheses
12/29/1998US5854292 Stimulating the differentiation of preadipocytic cells and therapies based thereon
12/29/1998US5854286 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors
12/29/1998US5854255 Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates
12/29/1998US5854240 Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide
12/29/1998US5854233 Method of treating liver disease and like indications with vasodilating agents
12/29/1998US5854231 Pharmaceutical composition for inhibiting the growth of cancers
12/29/1998US5854226 Pharmaceutical composition
12/29/1998US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
12/29/1998US5854022 Polynucleotides encoding a CD53-like transmembrane protein
12/29/1998US5854020 TCSTS polynucleotides
12/29/1998US5854016 Creba Isoform
12/29/1998US5853997 Human protein phosphatase
12/29/1998US5853753 Liposomes, method of preparing the same and use thereof in the preparation of drugs
12/29/1998US5853742 Cosmetic compositions containing lactate dehydrogenase inhibitors
12/29/1998US5853732 Pharmaceutical compositions containing kukui nut oil
12/29/1998US5853003 Treatment and diagnosis of respiratory disorders using fluorocarbon liquids
12/29/1998CA2171281C Immunomodulating compositions from bile
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/26/1998CA2235778A1 Novel glmu
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998058066A1 New human lysophospholipase
12/23/1998WO1998057990A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/23/1998WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998WO1998057980A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057979A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057662A2 Therapeutic systems
12/23/1998WO1998057656A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998WO1998057651A1 Compositions and methods for preventing restenosis following revascularization procedures
12/23/1998WO1998057649A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
12/23/1998WO1998057643A1 Use of draflazine-analogues for treating pain
12/23/1998WO1998057635A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
12/23/1998WO1998057634A1 Treatment of diabetes with thiazolidinedione and metformin
12/23/1998WO1998057633A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
12/23/1998WO1998057627A1 Dietary compositions for enhancing metabolism and alleviating oxidative stress
12/23/1998EP0885966A2 Novel compouds
12/23/1998EP0885965A2 Histidine kinase polypeptides
12/23/1998EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885959A2 Human Wnt-5b protein
12/23/1998EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator
12/23/1998EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885308A1 Compositions and methods of making embryonic stem cells
12/23/1998EP0885297A1 Novel era
12/23/1998EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/23/1998EP0885005A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
12/23/1998EP0714300B1 Methods for modulating the human sexual response
12/23/1998EP0610368B1 Treatment of acne or of pseudofolliculitis barbae
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CN1202824A Combinational therapeutic methods employing nitric oxide scavengers
12/23/1998CN1202823A Hydrolysis-optimized liplid emulsions and use thereof
12/23/1998CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness
12/23/1998CN1202818A Solubilisation method
12/23/1998CA2698626A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998CA2294563A1 New human lysophospholipase
12/23/1998CA2294519A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998CA2294134A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
12/23/1998CA2294011A1 Use of draflazine-analogues for treating pain
12/23/1998CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998CA2292608A1 Therapeutic systems for activation prodrugs
12/23/1998CA2287540A1 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/23/1998CA2241389A1 Methods of modulating muscle contraction
12/22/1998US5852173 TNF receptor death ligand proteins and inhibitors of ligand binding
12/22/1998US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
12/22/1998US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy
12/22/1998US5852044 Use of NK1 receptor antagonists for preparing cardio-regulatory drugs
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5852000 Cardiac rehabilitation agent
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851798 Nucleic acid encoding human GPR14 receptor
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851540 Composition, barrier film, and method for preventing contact dermatitis
12/20/1998CA2235444A1 Novel compounds
12/20/1998CA2235442A1 Response regulator
12/20/1998CA2235441A1 Novel compounds
12/20/1998CA2235437A1 Novel compounds
12/20/1998CA2235435A1 Novel compounds
12/20/1998CA2235433A1 Novel compounds
12/20/1998CA2235422A1 Novel compounds
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998057176A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/17/1998WO1998057175A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
12/17/1998WO1998056925A1 Human protein phosphatase ii-c-like protein
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 1151